Published On: Wed, Oct 19th, 2016

Analyst Review: Hill-Rom Holdings Inc (NYSE:HRC)


A number of investment brokers have recently updated their price targets on shares of Hill-Rom Holdings Inc (NYSE:HRC).

Most recent broker ratings

06/16/2016 – Hill-Rom Holdings Inc was upgraded to “overweight” by analysts at Morgan Stanley. They now have a USD 62 price target on the stock.

01/21/2016 – Hill-Rom Holdings Inc was upgraded to “overweight” by analysts at KeyBanc. They now have a USD 59 price target on the stock.

12/16/2015 – Hill-Rom Holdings Inc was upgraded to “buy” by analysts at Northcoast Research.

09/23/2015 – Hill-Rom Holdings Inc had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 61 price target on the stock.

05/06/2015 – Hill-Rom Holdings Inc was upgraded to “buy” by analysts at Zacks. They now have a USD 56 price target on the stock.

04/06/2015 – Hill-Rom Holdings Inc was upgraded to “buy” by analysts at Bank of America Merrill Lynch.

06/25/2014 – Hill-Rom Holdings Inc had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 43 price target on the stock.

02/10/2014 – Hill-Rom Holdings Inc was downgraded to “neutral” by analysts at Ned Davis Research.

10/25/2013 – Hill-Rom Holdings Inc was downgraded to “market perform” by analysts at Wells Fargo.

The share price of Hill-Rom Holdings Inc (NYSE:HRC) was up +0.60% during the last day of trading, with a day high of 60.31. 329722 shares were traded during the last session.

The stock’s 50 day moving average is 60.22 and its 200 day moving average is 54.03. The stock’s market capitalization is 3.92B. Hill-Rom Holdings Inc has a 52-week low of 42.99 and a 52-week high of 63.12.

Hill-Rom Holdings, Inc. is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions. The Company sells and rents its specialty frames and surfaces, and mobility solutions, as well as its clinical workflow solutions, in the United States and Canada through its North America Patient Support Systems segment, and in regions outside of the United States and Canada through its International Patient Support Systems segment. Its Front Line Care segment globally sells and rents respiratory care products, and sells medical diagnostic equipment and a diversified portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases. Under its Surgical Solutions segment, the Company sells its surgical products globally.